PAR PHARMACEUTICAL COMPANIES, INC. Earnings Per Share (Diluted)
PAR PHARMACEUTICAL COMPANIES, INC. reported Earnings Per Share (Diluted) of $1.38 per share for the 3-month period ending 2012-06-30, per its 10-Q filed 2012-08-02.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareDiluted · last filed 2012-08-02
- PAR PHARMACEUTICAL COMPANIES, INC. earnings per share, diluted for the quarter ending 2012-06-30 was $1.38, a 452.00% increase year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. earnings per share, diluted for the quarter ending 2012-03-31 was -$0.79.
- PAR PHARMACEUTICAL COMPANIES, INC. earnings per share, diluted for the quarter ending 2011-12-31 was $1.41, a 193.75% increase year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. earnings per share, diluted for the quarter ending 2011-09-30 was $0.60, a 30.23% decline year-over-year.
- PAR PHARMACEUTICAL COMPANIES, INC. earnings per share, diluted for fiscal 2011 was -$0.73, a 128.08% decline from fiscal 2010.
- PAR PHARMACEUTICAL COMPANIES, INC. earnings per share, diluted for fiscal 2010 was $2.60, a 15.56% increase from fiscal 2009.
- PAR PHARMACEUTICAL COMPANIES, INC. earnings per share, diluted for fiscal 2009 was $2.25.
| Period end | Earnings Per Share, Diluted 3 month | Earnings Per Share, Diluted 6 month | Earnings Per Share, Diluted 9 month | Earnings Per Share, Diluted 12 month |
|---|---|---|---|---|
| 2012-06-30 | $1.38 10-Q · filed 2012-08-02 | $0.61 10-Q · filed 2012-08-02 | $2.04 derived: net income ÷ weighted average shares · filed 2012-08-02 | $2.63 derived: net income ÷ weighted average shares · filed 2012-08-02 |
| 2012-03-31 | -$0.79 10-Q · filed 2012-05-08 | $0.64 derived: net income ÷ weighted average shares · filed 2012-05-08 | $1.24 derived: net income ÷ weighted average shares · filed 2012-05-08 | $1.48 derived: net income ÷ weighted average shares · filed 2012-08-02 |
| 2011-12-31 | $1.41 10-K · filed 2012-02-28 | $2.02 derived: net income ÷ weighted average shares · filed 2012-02-28 | $2.27 derived: net income ÷ weighted average shares · filed 2012-08-02 | -$0.73 10-K · filed 2012-02-28 |
| 2011-09-30 | $0.60 10-K · filed 2012-02-28 | $0.84 derived: net income ÷ weighted average shares · filed 2012-08-02 | -$2.17 10-Q · filed 2011-11-02 | -$1.66 derived: net income ÷ weighted average shares · filed 2012-08-02 |
| 2011-06-30 | $0.25 10-Q · filed 2012-08-02 | -$2.80 10-Q · filed 2012-08-02 | -$2.28 derived: net income ÷ weighted average shares · filed 2012-08-02 | -$1.44 derived: net income ÷ weighted average shares · filed 2012-08-02 |
| 2011-03-31 | -$3.07 10-Q · filed 2012-05-08 | -$2.55 derived: net income ÷ weighted average shares · filed 2012-05-08 | -$1.70 derived: net income ÷ weighted average shares · filed 2012-05-08 | -$1.19 derived: net income ÷ weighted average shares · filed 2012-05-08 |
| 2010-12-31 | $0.48 10-K · filed 2012-02-28 | $1.33 derived: net income ÷ weighted average shares · filed 2012-02-28 | $1.85 derived: net income ÷ weighted average shares · filed 2012-02-28 | $2.60 10-K · filed 2012-02-28 |
| 2010-09-30 | $0.86 10-K · filed 2012-02-28 | $1.38 derived: net income ÷ weighted average shares · filed 2012-02-28 | $2.12 10-Q · filed 2011-11-02 | |
| 2010-06-30 | $0.52 10-K · filed 2012-02-28 | $1.27 10-Q · filed 2011-08-03 | ||
| 2010-03-31 | $0.75 10-K · filed 2012-02-28 | |||
| 2009-12-31 | $2.25 10-K · filed 2012-02-28 |